Endpoints News May 31, 2026 #ASCO26: Summit, Akeso drug reduces death by 34% in China lung cancer study
Endpoints News May 31, 2026 #ASCO26: Personalized cancer vaccines may help brain cancer patients live longer
Endpoints News May 30, 2026 #ASCO26: Grail’s cancer blood test isn’t ready for widespread use, experts say
Endpoints News May 30, 2026 Can AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and more
Endpoints News May 29, 2026 AstraZeneca seeks path for failed antibody; Imfinzi, Tremfya label expansions
Endpoints News May 29, 2026 Agios ends development of tebapivat in low-risk MDS following subpar results
Endpoints News May 29, 2026 David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at Phlow
Endpoints News May 29, 2026 Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs
Endpoints News May 28, 2026 #ASCO26: After leaving Legend, Frank Fan is ready to showcase his next project